Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoinette S Perry

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
BJU International|April 8, 2015
Improving multivariable prostate cancer risk assessment using the Prostate Health IndexRobert W Foley, Laura Gorman, Neda Sharifi, et al.
The Prostate|March 11, 2020
Development of a multivariable risk model integrating urinary cell DNA methylation and cell-free RNA data for the detection of significant prostate cancerShea P Connell, Eve O'Reilly, Alexandra Tuzova, et al.
Cell Cycle (Georgetown, Tex.)|August 3, 2010
MAD2 downregulation in hypoxia is independent of promoter hypermethylationMaria Prencipe, Aloysius McGoldrick, Antoinette S Perry, et al.
International Journal of Cancer|March 8, 2023
Unveiling the epigenomic mechanisms of acquired platinum-resistance in high-grade serous ovarian cancerRomina Silva, Kate Glennon, Michael Metoudi, et al.
Research Involvement and Engagement|October 11, 2023
Involving patients in healthcare research is well documented but can it work in lab-based research?Adele E Connor, Claire Hughes, Lea Schäfer, et al.
Genome Research|October 28, 2010
Localized hypermutation and associated gene losses in legume chloroplast genomesAlan M Magee, Sue Aspinall, Danny W Rice, et al.
Clinical Genitourinary Cancer|March 27, 2024
IMPROVER (Involving Men with Prostate Cancer in Engaged Research): Assessing Patient Experience With Testing, Diagnosis, And SurveillanceMarc Walsh, Asia Jordan, Lea Schäfer, et al.
Clinical Epigenetics|November 25, 2018
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancerFang Zhao, Ekaterina Olkhov-Mitsel, Shivani Kamdar, et al.
Cancer Biology & Therapy|December 25, 2008
The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkersRuth Foley, Laure Marignol, Arun Z Thomas, et al.
International Journal of Cancer|August 24, 2012
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancerAntoinette S Perry, Gillian O'Hurley, Omer A Raheem, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
BJU International|April 8, 2015
Improving multivariable prostate cancer risk assessment using the Prostate Health IndexRobert W Foley, Laura Gorman, Neda Sharifi, et al.
The Prostate|March 11, 2020
Development of a multivariable risk model integrating urinary cell DNA methylation and cell-free RNA data for the detection of significant prostate cancerShea P Connell, Eve O'Reilly, Alexandra Tuzova, et al.
Cell Cycle (Georgetown, Tex.)|August 3, 2010
MAD2 downregulation in hypoxia is independent of promoter hypermethylationMaria Prencipe, Aloysius McGoldrick, Antoinette S Perry, et al.
International Journal of Cancer|March 8, 2023
Unveiling the epigenomic mechanisms of acquired platinum-resistance in high-grade serous ovarian cancerRomina Silva, Kate Glennon, Michael Metoudi, et al.
Research Involvement and Engagement|October 11, 2023
Involving patients in healthcare research is well documented but can it work in lab-based research?Adele E Connor, Claire Hughes, Lea Schäfer, et al.
Genome Research|October 28, 2010
Localized hypermutation and associated gene losses in legume chloroplast genomesAlan M Magee, Sue Aspinall, Danny W Rice, et al.
Clinical Genitourinary Cancer|March 27, 2024
IMPROVER (Involving Men with Prostate Cancer in Engaged Research): Assessing Patient Experience With Testing, Diagnosis, And SurveillanceMarc Walsh, Asia Jordan, Lea Schäfer, et al.
Clinical Epigenetics|November 25, 2018
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancerFang Zhao, Ekaterina Olkhov-Mitsel, Shivani Kamdar, et al.
Cancer Biology & Therapy|December 25, 2008
The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkersRuth Foley, Laure Marignol, Arun Z Thomas, et al.
International Journal of Cancer|August 24, 2012
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancerAntoinette S Perry, Gillian O'Hurley, Omer A Raheem, et al.
Pageof 5